Meningioma | NYU Langone Health
Perlmutter Cancer Center neurosurgeons, neurologists, radiation oncologists, and rehabilitation doctors work together to manage meningiomas.
Meniscus Tears | NYU Langone Health
NYU Langone doctors are experts at diagnosing meniscus tears and offer comprehensive, personalized treatment plans for this knee injury.
Menopause | NYU Langone Health
At NYU Langone, menopause specialists, reproductive endocrinologists, and researchers work together to help people manage menopause symptoms.
Mental & Behavioral Health | NYU Langone Health
NYU Langone psychiatrists and psychologists specialize in treating mental and behavioral health conditions in adults and children.
Mesenteric Ischemia | NYU Langone Health
NYU Langone vascular specialists manage mesenteric ischemia, a rare and serious condition that limits blood flow to the intestines.
Mesoscopic Biomarkers of Neurodegeneration and Inflammation with Diffusion MRI
In this study, novel diffusion MRI markers in brain white matter will be evaluated to yield clinically feasible non-invasive MR markers that are sensitive and specific to diffuse neurodegenerative and inflammatory processes in brain white matter of Multiple Sclerosis patients. The white matter microstructure markers will be evaluated in their ability to track disease progression, both in a cross-sectional and longitudinal design in MS patients with a varying range of disability. Ultimately, the MRI pipeline for estimating WM microstructure markers will be straightforwardly extendable beyond MS, to help understand and quantify neurodegeneration and inflammation in other neurological diseases.
Metabolomics of World Trade Center-Lung Injury: Biomarker Validation Assessment and Dietary Intervention: Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial
This is a dietary intervention study that will examine the therapuetic effect of a Calorie Restricted Mediterranean (LoCalMed) diet on clinical endpoints such as FEV1, FeNO, vascular stiffness, and show concurrent changes of targeted biomarkers and quality of life measures. We will compare BMI changes, lung function, targeted biomarkers, quality of life measures, FeNO, and pulse wave velocity (PWV) pre- to post-intervention.
Metastatic Brain Tumors | NYU Langone Health
Perlmutter Cancer Center doctors treat people who have metastatic brain tumors, cancers that have spread to the brain from another part of the body.
METRO Lupus Consortium
The purpose of this study is to learn more about patients with lupus ("systemic lupus erythematosus" or "SLE") who may have injury to their kidney which is called lupus nephritis (LN). The goal of this study is to increase the number of new diagnostics and therapies for patients, and to reduce the time and cost of developing these new treatment options.
mHealth-CArdiac REhabilitation for INOCA (INOCA-CARE)
This study will enroll participants with the condition condition called Ischemia with No-Obstructive Coronary Arteries (INOCA), which means the participant has "open arteries" (no major heart artery is blocked at least halfway). The purpose of this study is to find out if an exercise program done at home, called mobile health cardiac rehabilitation or mHealth-CR, can improve the health and quality of life of patients with INOCA. The purpose of this study is to find out if an exercise program done at home, called mobile health cardiac rehabilitation or mHealth-CR, can improve the health and quality of life of patients with INOCA. In order to understand if it does, we need to divide the participants into 2 groups, mHealth-CR group and usual care group, and compare the results. Both groups will receive the usual medical care determined by their doctor and will receive a Fitbit to track their activity. The main difference between the 2 groups is that only one group (the mHealth-CR group) will get access to the mHealth-CR app (Corrie health) on their mobile phone and will work with an exercise therapist who will create a personalized exercise plan to be followed for 3 months. Interested potential eligible participants will join a screening visit (remote) in which, if they agree to participate in the study, they will sign an informed consent form. After consent, the study participation will involve 2 in-person visits (at baseline and 3 months) and 2 virtual visits (at 6 and 12 months). There is no cost for participating in the study. Participants will receive compensation for travel and time. They will be paid $100 for completion of the baseline, $75 for their in-person follow-up visit at 3 months, and $50 for each of their remote follow-up visits: 6-month visit and 12-month visit. For more information about the INOCA-CARE research study please send us a message here or email us at inoca@nyulangone.org.